Ipamorelin

Ipamorelin is a selective growth hormone secretagogue and pentapeptide that functions as an agonist at the ipamorelin peptide  growth hormone secretagogue receptor (GHS-R), stimulating the pituitary gland to release growth hormone in a highly targeted fashion. What distinguishes Ipamorelin from other growth hormone-releasing peptides in research is its selectivity. Studies have demonstrated that it stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels, making it a particularly clean model compound for studying isolated GH secretagogue effects. Research has examined Ipamorelin’s ability to increase plasma GH concentrations in a dose-dependent and pulsatile manner, closely mimicking the natural physiology of GH secretion. Downstream effects on IGF-1 levels, lean muscle protein synthesis, and fat metabolism have also been subjects of investigation, as these are key mediators of growth hormone’s anabolic and body composition effects. Researchers have also studied Ipamorelin for potential applications in age-related GH decline, bone density research, and recovery from physiological stress. Its favourable selectivity profile and well-characterised pharmacokinetics make it one of the most frequently used peptides in growth hormone secretagogue research. ipamorelin peptide